AC Immune
Lydie LAGACHE has extensive work experience in the pharmaceutical industry. Lydie began their career in 1988 as a secretary at Fournier Pharma and worked there until 1993. Lydie then joined ASTRA ZENECA as a Technicien Recherche Clinique from 1994 to 2002. In 2007, Lydie joined Innate Pharma and held various roles, including Supply Chain Coordinator & Clinical Trial Manager, Global Supply Chain Manager, and Clinical Trial Manager & Supply Chain Coordinator. Lydie worked at Innate Pharma until 2022. Currently, Lydie works as a Clinical Supply Chain Lead at AC Immune, starting in May 2022.
Lydie Lagache obtained a Certification in BASICS Supply Chain Management from APICS in 2017.
This person is not in any offices
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.